Liver Cancer
Hepatocellular carcinoma (HCC) is a primary form of liver cancer that typically arises in individuals with chronic liver disease, often leading to symptoms such as weight loss, abdominal pain, and jaundice.
Hepatocellular Carcinoma: 68Ga-PSMA PET Imaging Study
We are evaluating a new imaging method to see if it can better detect recurrence of liver cancer in patients who have been treated before. This study aims to improve monitoring and treatment strategies for these patients.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hopital Beaujon
Gastro-entérologie et hépatologie
Clichy, France
Hopital Beaujon
Nuclear Medecine
Clichy, France
Centre Hospitalier Universitaire De Nantes
Nuclear Medecine
Nantes, France
Sponsor: Centre Hospitalier Universitaire De Nantes
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.